scRNA-Seq Analysis Revealed CAFs Regulating HCC Cells via PTN Signaling
Open Access
- 1 November 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 11, 2269-2281
Abstract
Background: Cancer-associated fibroblasts (CAFs) play a pivotal role in shaping the microenvironment of hepatocellular carcinoma (HCC). However, the mechanisms through which CAFs influence the progression of HCC remain incompletely understood. Methods: Single-cell RNA sequencing datasets (GSE158723 and GSE112271) were retrieved from the Gene Expression Omnibus (GEO) database at the National Center for Biotechnology Information (NCBI) and analyzed using R software. Our analysis suggested that CAFs may promote liver cancer cell development, possibly through the interaction of pleiotrophin (PTN) and syndecan-2 (SDC2). Clinical samples from HCC patients were collected and processed into frozen sections and single-cell suspensions for Masson staining, immunofluorescence staining, and flow cytometry. Additionally, Huh7 liver cancer cells and LO2 normal liver cells were cultured and subjected to immunofluorescence assays using cell slides. Results: The proportion of CAFs in cancerous tissues was higher than in adjacent non-cancerous tissues, and pleiotrophin (PTN) expression was elevated in cancer tissues compared to adjacent tissues. These findings aligned with the results of the single-cell RNA sequencing (scRNA-seq) analysis. Furthermore, SDC2 expression was significantly upregulated in Huh7 liver cancer cells compared to LO2 normal liver cells. Discussion: This study suggests that CAFs may contribute to HCC progression via the PTN/SDC2 signaling pathway. Our findings provide deeper insights into the interactions between CAFs and HCC cells within the tumor microenvironment (TME).Keywords
This publication has 40 references indexed in Scilit:
- LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiationOncogenesis, 2019
- A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancerPLOS ONE, 2018
- Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growthNature Communications, 2017
- Pleiotrophin, a target of miR‐384, promotes proliferation, metastasis and lipogenesis in HBV‐related hepatocellular carcinomaJournal of Cellular and Molecular Medicine, 2017
- Pleiotrophin as a potential biomarker in breast cancer patientsClinica Chimica Acta, 2017
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient PrognosisGastroenterology, 2017
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapyAnnals of Oncology, 2016
- PTN signaling: Components and mechanistic insights in human ovarian cancerMolecular Carcinogenesis, 2014
- Functional Receptors and Intracellular Signal Pathways of Midkine (MK) and Pleiotrophin (PTN)Biological and Pharmaceutical Bulletin, 2014
- Pleiotrophin Enhances Clonal Growth and Long-Term Expansion of Human Embryonic Stem CellsStem Cells, 2007